Skip to main content

IN-LICENSING

CSL Seqirus has extensive experience in commercialising pharmaceutical and vaccine products for international partners in Australia and New Zealand. We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital.

Consumer Pain Campaign AU 3

In-licensing for New Zealand

CSL Seqirus is proud to have high performing primary and specialty care sales teams in New Zealand. With expertise in both private and reimbursed products, we can help you achieve your commercial goals.

Contact for In-licensing

Find out how CSL Seqirus can help you enter the New Zealand market by contacting our team.

Phone: +61 (0) 3 9389 2885 or +61 (0) 3 9389 2196 

Strategic Market Entry

Strategic Market Entry

CSL Seqirus has dedicated regulatory and health economics teams to secure optimum labelling and pricing in Australia and New Zealand markets

Superior Performance

Performance Driven Teams

We have a robust track record building strong brands and achieving rapid market penetration in reimbursed and private markets in Australia and New Zealand.

We make it our own

We Make it Our Own

We make a significant investment and focus our resources during all phases of your product’s lifecycle.

Partnering flexibility

Partnering Flexibility

Our team has a great ability to adapt to our partner’s needs.

AP-CRP-23-0001

Seqirus privacy statement
Seqirus privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.